Artem

About Artem Andrianov, Ph.D., MBA

Professional in the integration of data-driven Risk-based Quality Management (RBQM) process in international clinical trials of pharmacology. Speaker at regional and global conferences such as: DIA, Health 2.0, DGGF, etc. 18+ years of experience in data quality projects and biostatistics for the pharmaceutical industry. Life passion: improving clinical research with RbM, driving the RBQM research to new frontiers for CROs, pharma and biotech companies.
Feb 2016

RBM.Cloud – a Unified Address for Risk-based Monitoring

By |2020-09-23T11:03:53+02:00February 19, 2016|News, RBQM Product Updates|0 Comments

In the nearest week-end Cyntegrity migrates all its Risk-based Monitoring services to one unified address: RBM.Cloud. The CRO oversight services will be later migrated to: CRO.Cloud.

Feb 2016

How to choose the right trial for RbM pilot?

By |2016-11-16T18:35:36+02:00February 9, 2016|Blog|0 Comments

A famous saying tells us that “experience often comes after one needs it”. Risk-based monitoring (RBM) is a major development and often fails in implementation due to its additional complexity and the variety of opinions of various stakeholders. In order to gain experience before one needs [...]

Feb 2016

6 New Features of @RACT 2.0

By |2020-09-23T11:04:33+02:00February 5, 2016|News, RBQM Product Updates|0 Comments

The free @RACT platform, which is used already by many companies, e.g., the first 50 users from big-pharma and CRO (e.g. Daiichi Sankyo, Merz, PPD, MedPace, INC Research etc.), was today updated with the new version 2.0. Besides hundreds of smaller improvements, there are 6 [...]

Jan 2016

RBM: Outlook for 2016 (Video)

By |2016-11-16T18:35:37+02:00January 15, 2016|Blog|0 Comments

The film unites Risk-based Monitoring (RBM) experts from a sponsor side, contract research organization, strategic advisers and technology providers. The experts provide outlook for Risk-based Monitoring for 2016: Dr. María Proupín-Pérez, PMP - Project Leader (PPH plus) Dr. Peter Schiemann - Managing Partner (Widler & Schiemann Ltd.) Moe [...]

Dec 2015

EarlyBird Ver. 3.5 available in SandBox

By |2020-09-23T11:07:59+02:00December 7, 2015|News, RBQM Product Updates|0 Comments

Cyntegrity has updated the SandBox environment with the Version 3.5 of the RBM solution EarlyBird. The most informative & understandable graphs, robust KRIs, clear performance indicators will turn your experience with RBM analytics to a real adventure! Test it yourself. Free. [...]

Nov 2015

How to Master the new EU Regulation with RBM? (French EPharma Day in Paris)

By |2016-11-16T18:35:41+02:00November 23, 2015|News|0 Comments

Meet Cyntegrity on French EPharma Day in Paris, which is dedicated to European Regulation and Data Transparency. On Wednesday, 25 November 2015, Cyntegrity will present "How to Master the new EU Regulation with Risk-based Monitoring (RBM)". The presentation will demonstrate that risk management is much wider [...]

Nov 2015

7 Weak Points of TransCelerate RACT

By |2018-07-04T06:07:12+02:00November 9, 2015|Blog|0 Comments

TransCelerate RACT offers a very useful methodology for study level risk assessments. Despite its standardized character and broad study risk scope, the RACT has some weaknesses. The way to address these common spreadsheet shortcomings is the deployment of dedicated technology together with a specialized user interface presenting the trial risks in a logical manner.

Go to Top